Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Finasteride + Minoxidil vs Minoxidil in Male Androgenetic Alopecia
NCT05990400Phase 3Unknown
- Sponsor
- Universitas Indonesia
- Start
- May 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of DA-4001C in androgenetic alopecia (AGA) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Hair density at 12 weeks, Hair diameter (mean thickness) at 12 weeks and 1 more. Status: unknown.
02
Drugs
DA-4001C
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT05990400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990400.